Workflow
Chip Cycle Recovery
icon
Search documents
Texas Instruments Gains After Analysts Point To Improving Orders, Early Signs Of Chip Cycle Recovery
Benzinga· 2026-01-28 19:21
Core Viewpoint - Texas Instruments Inc's stock rose after analysts raised price targets following a positive quarterly outlook despite slightly missing revenue and earnings expectations Financial Performance - The company reported Q4 revenue of $4.42 billion and earnings per share of $1.27, slightly below analyst forecasts of $4.44 billion and $1.30 per share, but revenue increased by 10% year-over-year [2] - For Q1, Texas Instruments projected revenue between $4.32 billion and $4.68 billion and earnings per share between $1.22 and $1.48, compared to consensus estimates of $4.42 billion in revenue and $1.26 per share in earnings [3] Analyst Ratings and Price Targets - Cantor Fitzgerald analyst Matthew Prisco maintained a Neutral rating and raised the price target from $190 to $225 [3] - Benchmark analyst Cody Acree reiterated a Buy rating and increased the price target from $220 to $250 [4] - Rosenblatt analyst Kevin Cassidy also maintained a Buy rating, raising the price target from $200 to $240 [4] Market Demand and Growth Outlook - Analysts noted improved momentum in the Industrial and Data Center segments, with Texas Instruments forecasting positive sequential growth for the first time since 2010 [5] - The company is experiencing a recovery supported by better order patterns, a growing backlog, and increased "turns" business, particularly in data centers and industrial markets [6][8] - Data center revenue surged 70% year-over-year in Q4, contributing significantly to overall growth [11] Segment Performance - Each segment contributed approximately 33% to 2025 revenue, with Industrial sales up 12% year-over-year and Automotive sales up 6%, despite sequential declines due to normal seasonality [9] - The data center segment is expected to exceed 12% of total revenue in 2026, up from about 9% in 2025 [12] Stock Performance - Texas Instruments stock increased by 9.25% to $214.87 following the positive outlook and guidance [13]